Fortress Biotech (FBIO) Income from Discontinued Operations (2017 - 2018)
Fortress Biotech (FBIO) posted quarterly Income from Discontinued Operations of 806000.0 for Q4 2018, down 14.62% quarter-over-quarter from 944000.0 in Q3 2018.
Powered by 
Analysis
Fortress Biotech (FBIO) Income from Discontinued Operations (2017 - 2018) Analysis & Trends
Fortress Biotech's Income from Discontinued Operations history runs 1 years deep, the most recent figure standing at 806000.0 for Q4 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | - |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | -7.12 Mn |
| Sep 30, 2018 | 3.59 Mn |
| Jun 30, 2018 | -6.92 Mn |
| Mar 31, 2018 | -2.08 Mn |
| Dec 31, 2017 | -1.21 Mn |
| Sep 30, 2017 | -3.96 Mn |
| Jun 30, 2017 | -184,000.00 |
| Mar 31, 2017 | 3.03 Mn |